Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Thrombosis and Haemostasis

• Publication date

  2008-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH07-11-0666PMID 18327397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation

  2007cited by this paper
• Acute lung injury

  2007influential reference
• Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs

  2007cited by this paper
• The tissue factor–factor VIIa complex: procoagulant activity, regulation, and multitasking

  2007cited by this paper
• Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome

  2007cited by this paper
• Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.

  2006cited by this paper
• Differential expression of tissue factor mRNA and protein expression in murine sepsis

  2006cited by this paper
• Inflammation and the activated protein C anticoagulant pathway.

  2006cited by this paper
• Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin

  2006cited by this paper
• Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis.

  2006cited by this paper
• Anticoagulant therapy for idiopathic pulmonary fibrosis.

  2005cited by this paper
• Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.

  2005cited by this paper
• Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation.

  2005cited by this paper
• Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.

  2005cited by this paper
• Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).

  2005cited by this paper
• Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application

  2004cited by this paper
• Factor VII activating protease (FSAP) inhibits growth factor‐mediated cell proliferation and migration of vascular smooth muscle cells.

  2004cited by this paper
• Macrophage Migration Inhibitory Factor Is Induced by Thrombin and Factor Xa in Endothelial Cells*

  2004cited by this paper
• Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma.

  2004cited by this paper
• Protein C and thrombomodulin in human acute lung injury.

  2003cited by this paper
• Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease.

  2003cited by this paper
• Activated protein C inhibits the expression of platelet-derived growth factor in the lung.

  2003cited by this paper
• Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.

  2003cited by this paper
• Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

  2003cited by this paper
• Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.

  2003cited by this paper
• Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

  2003cited by this paper
• Collagen Dissolution by Keratinocytes Requires Cell Surface Plasminogen Activation and Matrix Metalloproteinase Activity*

  2002cited by this paper
• Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice.

  2002cited by this paper
• Idiopathic pulmonary fibrosis: new insights in its pathogenesis.

  2002cited by this paper
• Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.

  2002cited by this paper
• Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.

  2001cited by this paper
• Thrombin Differentiates Normal Lung Fibroblasts to a Myofibroblast Phenotype via the Proteolytically Activated Receptor-1 and a Protein Kinase C-dependent Pathway*

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.

  2001cited by this paper
• Proteolytic activation and inactivation of the serine protease activity of plasma hyaluronan binding protein.

  2001cited by this paper
• Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

  2001influential reference
• Treatment of Severe Acute Respiratory Distress Syndrome: A Final Report on a Phase I Study

  2001cited by this paper
• Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy

  2001cited by this paper
• Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.

  2001cited by this paper
• Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

  2001cited by this paper
• uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration.

  2001cited by this paper
• High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial

  2001cited by this paper
• Thrombin Is a Potent Inducer of Connective Tissue Growth Factor Production via Proteolytic Activation of Protease-activated Receptor-1*

  2000cited by this paper
• Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation.

  2000cited by this paper
• Activation of proPHBSP, the Zymogen of a Plasma Hyaluronan Binding Serine Protease, by an Intermolecular Autocatalytic Mechanism

  2000cited by this paper
• Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.

  2000cited by this paper
• The FVII Activating Protease Cleaves Single-Chain Plasminogen Activators

  2000cited by this paper
• Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.

  2000cited by this paper
• Decreased Protein C Activation Is Associated With Abnormal Collagen Turnover in the Intraalveolar Space of Patients With Interstitial Lung Disease

  2000cited by this paper
• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

  2000cited by this paper
• Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

  2000cited by this paper
• Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosis.

  2000cited by this paper
• The acute respiratory distress syndrome.

  2000cited by this paper
• Enhanced Tissue Factor Pathway Activity and Fibrin Turnover in the Alveolar Compartment of Patients with Interstitial Lung Disease

  2000cited by this paper
• A protease isolated from human plasma activating factor VII independent of tissue factor.

  1999cited by this paper
• Antithrombin III in patients with severe sepsis

  1998cited by this paper
• Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

  1998cited by this paper
• Protein C anticoagulant system in patients with interstitial lung disease.

  1998cited by this paper
• Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis.

  1998cited by this paper
• Antithrombin III (ATILL) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study

  1998cited by this paper
• Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1.

  1998cited by this paper
• Tissue factor gene expression in the adipose tissues of obese mice.

  1998cited by this paper
• Heparin Improves Gas Exchange during Experimental Acute Lung Injury in Newborn Piglets

  1998cited by this paper
• Protein C anticoagulant system in patients with interstitial lung disease

  1998cited by this paper
• Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.

  1997cited by this paper
• Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin

  1997cited by this paper
• Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis.

  1997cited by this paper
• ATTENUATION OF ENDOTOXIN‐INDUCED PULMONARY VASCULAR INJURY BY ANTITHROMBIN III.: 653

  1997cited by this paper
• Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation.

  1997cited by this paper
• Antithrombin III (AT III) Prevents LPS-Induced Pulmonary Vascular Injury: Novel Biological Activity of AT III

  1997cited by this paper
• HEPARIN IMPROVES GAS EXCHANGE DURING EXPERIMENTAL ACUTE LUNG INJURY IN NEWBORN PIGLETS • 1587

  1997cited by this paper
• Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator.

  1996cited by this paper
• Thrombin Inhibitors Reduce Intrapulmonary Accumulation of Fibrinogen and Procoagulant Activity of Bronchoalveolar Lavage Fluid During Acute Lung Injury Induced by Pulmonary Overdistention in Newborn Piglets1

  1996cited by this paper
• Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications.

  1996cited by this paper
• Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

  1996cited by this paper
• The role of fibrin degradation products in neutrophil recruitment to the lung.

  1996cited by this paper
• Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III

  1996cited by this paper
• The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats.

  1996cited by this paper
• Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13.

  1996cited by this paper
• Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin

  1995cited by this paper
• Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.

  1995cited by this paper
• Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.

  1995cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper
• Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model.

  1994cited by this paper
• Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.

  1993cited by this paper
• Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells

  1993cited by this paper
• Procoagulant activity in bronchoalveolar fluids: no relationship with tissue factor pathway inhibitor activity.

  1992cited by this paper
• Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.

  1992cited by this paper
• Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome.

  1990cited by this paper
• Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals.

  1990cited by this paper
• Local activation of the coagulation and fibrinolysis systems in lung disease.

  1990cited by this paper
• Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs.

  1990cited by this paper
• Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.

  1990cited by this paper
• Prevention of adult respiratory distress syndrome with plasminogen activator in pigs.

  1990cited by this paper
• [Fibrin deposition and fibrinolysis in the pathogenesis of pulmonary fibrosis].

  1989cited by this paper
• Alveolitis and collapse in the pathogenesis of pulmonary fibrosis.

  1989cited by this paper
• Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.

  1989cited by this paper
• Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition.

  1989cited by this paper
• Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

  1988cited by this paper
• Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis.

  1988cited by this paper

• Pulmonary fibroblasts activated by the addition of TNF-α and IL-4 enhance lymphangiogenic capacity and ameliorate lung fibrosis in an allogeneic rat model

  2026cites this paper
• Application and prospects of lung organ-on-a-chip in the development of new drugs

  2025cites this paper
• Molecular signatures of alveolar type II cell differentiation in acute respiratory distress syndrome

  2025cites this paper
• Invasive Mechanical Ventilation and Risk of Hospital-Acquired Venous Thromboembolism

  2024cites this paper
• A bovine model of hypoxia-induced pulmonary hypertension reveals a gradient of immune and matrisome response with a complement signature found in circulation.

  2024cites this paper
• Asthma and coagulation: A (seemingly) strange couple and its pathophysiological and clinical implications

  2024cites this paper
• Hospital acquired venous thromboembolism during invasive mechanical ventilation in children: a single center, retrospective cohort study.

  2023cites this paper
• Prognostic value of ECG monitor findings in COVID-19

  2023cites this paper
• Hospital-Acquired Venous Thromboembolism and Invasive Mechanical Ventilation: A Report From the Children’s Hospital Acquired Thrombosis Consortium

  2023cites this paper
• Countermeasures against Pulmonary Threat Agents

  2023cites this paper
• Lung injury and oxidative stress induced by inhaled chlorine in mice is associated with proinflammatory activation of macrophages and altered bioenergetics.

  2023cites this paper
• Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models

  2022cites this paper
• Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise

  2022cites this paper
• Mechanical Ventilation and Hospital-Acquired Venous Thromboembolism Among Critically Ill Children.

  2022cites this paper
• Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape

  2022cites this paper
• Lung histopathological findings in COVID-19 disease – a systematic review

  2021cites this paper
• Molecular mechanisms of postintensive care syndrome

  2021influential citation
• Possible Potential Effects of Honey and Its Main Components Against Covid-19 Infection

  2021cites this paper
• Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae

  2020cites this paper
• Lactobacillus casei CRL431 modulates hemostatic activation induced by protein malnourishment and pneumococcal respiratory infection

  2020cites this paper
• Progressive Lung Injury, Inflammation and Fibrosis in Rats following Inhalation of Sulfur Mustard.

  2020cites this paper
• Dexmedetomidine alleviates LPS-induced acute lung injury via regulation of the p38/HO-1 pathway

  2020cites this paper
• COVID-19: The crucial role of blood coagulation and fibrinolysis

  2020cites this paper
• Severe Acute Lung Injury Related to COVID‐19 Infection: A Review and the Possible Role for Escin

  2020cites this paper
• COVID-19 and MS disease-modifying therapies

  2020cites this paper
• SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?

  2020cites this paper
• On Mechanisms Modulating Pulmonary Innate Immunity and Tissue Injury

  2020cites this paper
• Regeneration of Pulmonary Tissue in a Calf Model of Fibrinonecrotic Bronchopneumonia Induced by Experimental Infection with Chlamydia psittaci

  2020cites this paper
• Comparisons of acute inflammatory responses of nose-only inhalation and intratracheal instillation of ammonia in rats

  2019cites this paper
• Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury.

  2019cites this paper
• Pharmacoproteomics reveal novel protective activity of bromodomain containing 4 inhibitors on vascular homeostasis in TLR3-mediated airway remodeling.

  2019influential citation
• Electron confocal and atomic force microscopic analysis of platelets fibrin and erythrocytes in atopic asthma

  2018cites this paper
• Coagulation Factor XIIIA: biochemical properties underlying physiological function.

  2018cites this paper
• Primary Human Lung Alveolus‐on‐a‐chip Model of Intravascular Thrombosis for Assessment of Therapeutics

  2018cites this paper
• Substrate stiffness-dependent exacerbation of endothelial permeability and inflammation: mechanisms and potential implications in ALI and PH (2017 Grover Conference Series)

  2018cites this paper
• C 1 esterase inhibitor mediated protection from acute lung injury

  2017cites this paper
• Human airway trypsin‐like protease exerts potent, antifibrotic action in pulmonary fibrosis

  2017cites this paper
• Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury

  2017cites this paper
• Human airway trypsin-like protease, a serine protease involved in respiratory diseases.

  2017cites this paper
• Rho-kinase inhibitor treatment prevents pulmonary inflammation and coagulation in lipopolysaccharide-induced lung injury.

  2017cites this paper
• Actions of thrombin in the interstitium

  2016cites this paper
• Host-derived extracellular RNA promotes adhesion of Streptococcus pneumoniae to endothelial and epithelial cells

  2016cites this paper
• Establishment of Diagnosis for Early Metastasis

  2016cites this paper
• Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation

  2016cites this paper
• Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia

  2015cites this paper
• Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage

  2015cites this paper
• Nebulized recombinant human Tissue Factor Pathway Inhibitor attenuates coagulation and inflammation in rat models of direct and indirect lung injury

  2015cites this paper
• Are markers of fibrin turnover in blood and urine increased before and during exacerbation of asthma

  2015influential citation
• The tissue factor pathway in pneumonia

  2015cites this paper
• Studies on the host genetic resistance and susceptibility to influenza A virus

  2015cites this paper
• Tissue Factor and Tissue Factor Pathway Inhibitor in Nasal Mucosa and Nasal Secretions of Chronic Rhinosinusitis with Nasal Polyp

  2015cites this paper
• Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation.

  2015cites this paper
• Low molecular weight heparin may prevent acute lung injury induced by sepsis in rats.

  2015cites this paper
• Biomarkers in acute lung injury.

  2015cites this paper
• Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia

  2015cites this paper
• Chronic Rhinosinusitis and the Coagulation System

  2015cites this paper
• N-acetyl cysteine improves the effects of corticosteroids in a mouse model of chlorine-induced acute lung injury.

  2015cites this paper
• Pulmonary tuberculosis induces a systemic hypercoagulable state.

  2015cites this paper
• The cytoprotective effects of endogenous activated protein C reduce activation of coagulation during murine pneumococcal pneumonia and sepsis.

  2015cites this paper
• Serum Analysis of Coagulation Factors in IPF and NSIP

  2014cites this paper
• Thrombin promotes proliferation of human lung fibroblasts via protease activated receptor‐1‐dependent and NF‐κB‐independent pathways

  2014cites this paper
• Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses

  2014cites this paper
• Recognizing and Treating Comorbidities of IPF

  2014cites this paper
• Coagulation and fibrinolysis in tuberculosis, melioidosis and beyond

  2014cites this paper
• Molecular pathology of emerging coronavirus infections

  2014cites this paper
• Modulation of the inflammation–coagulation interaction during pneumococcal pneumonia by immunobiotic Lactobacillus rhamnosus CRL1505: Role of Toll‐like receptor 2

  2014cites this paper
• CT Findings of Pulmonary Involvement in Antiphospholipid Syndrome

  2013cites this paper
• Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci

  2013cites this paper
• Inhaled unfractionated heparin improves abnormalities of alveolar coagulation, fibrinolysis and inflammation in endotoxemia-induced lung injury rats.

  2013cites this paper
• Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury

  2013influential citation
• Lactobacillus rhamnosus CRL1505 beneficially modulates the immuno-coagulative response after pneumococcal infection in immunocompromised malnourished mice.

  2013cites this paper
• Immunobiotics and Inflammation-Coagulation

  2013cites this paper
• Developmental regulation of inflammatory cytokine-mediated Stat3 signaling: the missing link between intrauterine growth restriction and pulmonary dysfunction?

  2012cites this paper
• Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses

  2012cites this paper
• Plasmin as a proinflammatory cell activator

  2012cites this paper
• A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome

  2012cites this paper
• Asthma and coagulation.

  2012cites this paper
• Anti-Inflammatory and Anticoagulative Effects of Paeonol on LPS-Induced Acute Lung Injury in Rats

  2012cites this paper
• Coagulation cascade proteinases in lung injury and fibrosis.

  2012cites this paper
• TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.

  2012cites this paper
• Moutan cortex radicis improves lipopolysaccharide-induced acute lung injury in rats through anti-inflammation.

  2012cites this paper
• Coagulation and autoimmunity in scleroderma interstitial lung disease.

  2011influential citation
• Vitronectin in Vascular Context: Facets of a Multitalented Matricellular Protein

  2011cites this paper
• Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.

  2011cites this paper
• Cardiovascular , Pulmonary and Renal Pathology Protease-Activated Receptor-2 Induces Myofibroblast Differentiation and Tissue Factor Up-Regulation during Bleomycin-Induced Lung Injury Potential Role in Pulmonary Fibrosis

  2010cites this paper
• Titration of mean airway pressure and FiO2 during high frequency oscillatory ventilation in a porcine model of acute lung injury.

  2010cites this paper
• The role of protease‐activated receptors PAR‐1 and PAR‐2 in the repair of 16HBE 14o− epithelial cell monolayers in vitro

  2010cites this paper
• Up-regulation of the Extrinsic Coagulation Pathway in Acute Asthma—A Case Study

  2010cites this paper
• Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study.

  2010cites this paper
• The Feasibility of a Randomized Controlled Trial Investigating the Effects of Fish Oil - Eicosapentaenoic Acid (EPA) and Docosahexanoic Acid (DHA) - on Chronic Ventilator Patients in a Long-Term Acute Care Hospital (LTACH) Setting

  2009cites this paper
• Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids

  2009cites this paper
• Cutting edge research for novel therapies of heart and lung diseases

  2009cites this paper
• Urokinase: An Enzyme Linking Kidney and Lung Function

  2009cites this paper
• Long-term efficacy of surgical removal of pseudomembranes in a child with ligneous conjunctivitis treated with plasminogen eyedrops

  2008cites this paper
• ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells

  2008cites this paper
• From Molecules to Medicine: New Horizons in Vascular Biology and Thrombosis (Part II)

  2008cites this paper